These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 15015586

  • 21. Apoptosis resistance of MCF-7 breast carcinoma cells to ionizing radiation is independent of p53 and cell cycle control but caused by the lack of caspase-3 and a caffeine-inhibitable event.
    Essmann F, Engels IH, Totzke G, Schulze-Osthoff K, Jänicke RU.
    Cancer Res; 2004 Oct 01; 64(19):7065-72. PubMed ID: 15466201
    [Abstract] [Full Text] [Related]

  • 22. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
    Shi R, Peng H, Yuan X, Zhang X, Zhang Y, Fan D, Liu X, Xiong D.
    J Cell Biochem; 2013 Aug 01; 114(8):1890-900. PubMed ID: 23494858
    [Abstract] [Full Text] [Related]

  • 23. Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance.
    Friedrich K, Wieder T, Von Haefen C, Radetzki S, Jänicke R, Schulze-Osthoff K, Dörken B, Daniel PT.
    Oncogene; 2001 May 17; 20(22):2749-60. PubMed ID: 11420687
    [Abstract] [Full Text] [Related]

  • 24. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C, Wellham LL.
    Anticancer Res; 2003 May 17; 23(3B):2681-90. PubMed ID: 12894558
    [Abstract] [Full Text] [Related]

  • 25. P-glycoprotein expression does not change the apoptotic pathway induced by curcumin in HL-60 cells.
    Bielak-Mijewska A, Piwocka K, Magalska A, Sikora E.
    Cancer Chemother Pharmacol; 2004 Feb 17; 53(2):179-85. PubMed ID: 14530869
    [Abstract] [Full Text] [Related]

  • 26. The nitroxide Tempol modulates anthracycline resistance in breast cancer cells.
    Gariboldi MB, Terni F, Ravizza R, Meschini S, Marra M, Condello M, Arancia G, Monti E.
    Free Radic Biol Med; 2006 Apr 15; 40(8):1409-18. PubMed ID: 16631531
    [Abstract] [Full Text] [Related]

  • 27. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM, El-Awady RA, Abdel Alim MA, Abdel Wahab AH.
    Cell Biochem Biophys; 2009 Apr 15; 55(2):95-105. PubMed ID: 19593673
    [Abstract] [Full Text] [Related]

  • 28. Modulation of multidrug resistance gene expression in human breast cancer cells by (-)-gossypol-enriched cottonseed oil.
    Ye W, Chang HL, Wang LS, Huang YW, Shu S, Dowd MK, Wan PJ, Sugimoto Y, Lin YC.
    Anticancer Res; 2007 Apr 15; 27(1A):107-16. PubMed ID: 17352222
    [Abstract] [Full Text] [Related]

  • 29. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells.
    Hsu YL, Kuo PL, Lin LT, Lin CC.
    J Pharmacol Exp Ther; 2005 Apr 15; 313(1):333-44. PubMed ID: 15626723
    [Abstract] [Full Text] [Related]

  • 30. A novel anthracene derivative, MHY412, induces apoptosis in doxorubicin-resistant MCF-7/Adr human breast cancer cells through cell cycle arrest and downregulation of P-glycoprotein expression.
    De U, Chun P, Choi WS, Lee BM, Kim ND, Moon HR, Jung JH, Kim HS.
    Int J Oncol; 2014 Jan 15; 44(1):167-76. PubMed ID: 24190517
    [Abstract] [Full Text] [Related]

  • 31. [Construction of glucosylceramide synthase-specific siRNA expression vector and its efficiency in reversal of drug resistance in breast carcinoma cells].
    Sun YL, Zhou GY, Li KN, Li WT, Song XR, Gao P.
    Zhonghua Yi Xue Za Zhi; 2005 Mar 02; 85(8):518-21. PubMed ID: 15949329
    [Abstract] [Full Text] [Related]

  • 32. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH, Shin YJ, Won AJ, Lee BM, Choi WS, Jung JH, Chung HY, Kim HS.
    Biochim Biophys Acta; 2014 Jan 02; 1840(1):615-25. PubMed ID: 24161697
    [Abstract] [Full Text] [Related]

  • 33. Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol.
    Xu D, Lu Q, Hu X.
    Cancer Lett; 2006 Nov 18; 243(2):274-80. PubMed ID: 16406853
    [Abstract] [Full Text] [Related]

  • 34. Human breast cancer MCF-7 cell line contains inherently drug-resistant subclones with distinct genotypic and phenotypic features.
    Devarajan E, Chen J, Multani AS, Pathak S, Sahin AA, Mehta K.
    Int J Oncol; 2002 May 18; 20(5):913-20. PubMed ID: 11956583
    [Abstract] [Full Text] [Related]

  • 35. Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes.
    Wang GW, Klein JB, Kang YJ.
    J Pharmacol Exp Ther; 2001 Aug 18; 298(2):461-8. PubMed ID: 11454906
    [Abstract] [Full Text] [Related]

  • 36. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
    Choi J, Yip-Schneider M, Albertin F, Wiesenauer C, Wang Y, Schmidt CM.
    J Surg Res; 2008 Dec 18; 150(2):219-26. PubMed ID: 18468633
    [Abstract] [Full Text] [Related]

  • 37. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.
    Shaik MS, Chatterjee A, Singh M.
    J Pharm Pharmacol; 2004 Jul 18; 56(7):899-907. PubMed ID: 15233869
    [Abstract] [Full Text] [Related]

  • 38. Nuclear factor-kappa B and apoptosis inducing factor activation by doxorubicin analog WP744 in SH-SY5Y neuroblastoma cells.
    Wu J, Harris NL, Inge TH.
    J Surg Res; 2004 Dec 18; 122(2):231-9. PubMed ID: 15555623
    [Abstract] [Full Text] [Related]

  • 39. Modulation of DNA methylation levels sensitizes doxorubicin-resistant breast adenocarcinoma cells to radiation-induced apoptosis.
    Luzhna L, Kovalchuk O.
    Biochem Biophys Res Commun; 2010 Feb 05; 392(2):113-7. PubMed ID: 20034463
    [Abstract] [Full Text] [Related]

  • 40. Doxorubicin-formaldehyde conjugate, doxoform: induction of apoptosis relative to doxorubicin.
    Burke PJ, Koch TH.
    Anticancer Res; 2001 Feb 05; 21(4A):2753-60. PubMed ID: 11724351
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.